EXPERT TAKE

SigTuple’s cloud-based Artificial intelligence (AI) platform is a very powerful disruptive innovation, which can be of immense benefit to health-care providers, especially those in the diagnostic space. It has tremendous scope to scale up at a rapid pace, and potential to replace the current practices with ease, and well adaptable in both the existing and new market space.

The technology can address many challenges of healthcare providers, in terms of quality, trained manpower, timely delivery of reports, infrastructure, cost and accuracy. It has a multimillion dollar potential, with global utility.

The platform is sturdy and fairly validated. The need is to roll it out commercially in clinical settings. This will help gain acceptability from health care providers. Once done, the sky is the limit. The new funds will definitely help them achieve perfection and enter the commercial space.

All innovations, to some extent, represent uncertainty. Established players and traditional practices adopted by providers will definitely create some resistance. It can overcome this conflict by listing validated and verified data, associating with established service providers, strategic positioning and committed marketing, with technical reinforcement.

As the base platform is very scientific, it should be used for introducing diverse offerings, with a focus on regional need. Probably, a diverse portfolio will gain acceptability very fast. Once that happens, it will become an opportunity over a billion dollars.